Results
Title

Novel drugs from marine microorganisms.

Authors

Javed, Faraza; Qadir, M. Imran; Janbaz, Khalid Hussain; Ali, Muhammad

Abstract

Marine microorganisms have expected mounting consideration on the basis of bioactive metabolites and propose an exclusive prospect to both enhance the amount of aquatic natural foodstuffs in clinical trials as well as speed up their progress. This review focuses particularly on those molecules, originated from marine microorganisms, presently in the medical pipeline that have been recognized or highly expected to be identified based on growing incidental evidence. Particularly karlotoxin class compounds, isolated from dinoflagellate Karlodinium veneficum, offer chances to create new molecules for control of cancer and high serum cholesterol levels.

Subjects

DRUGS; MARINE organisms; METABOLITES; MICROORGANISMS; DINOFLAGELLATES; BLOOD cholesterol; CANCER prevention

Publication

Critical Reviews in Microbiology, 2011, Vol 37, Issue 3, p245

ISSN

1040-841X

Publication type

Academic Journal

DOI

10.3109/1040841X.2011.576234